ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TTRX vs CYPH // FREE CASH FLOW YIELD

Turn Therapeutics Inc. (NASDAQ) VS. Cypherpunk Technologies Inc. (NASDAQ) • 15-METRIC TALLY: TTRX 1 — CYPH 4
▲ FREE CASH FLOW YIELD LEADER: TTRX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TTRX VS. CYPH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TTRX CYPH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -28.30% -23.30% -5.00 CYPH /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -0.78% -12.31% +11.53 TTRX /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 CYPH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.8 50.4 -6.60 CYPH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 66.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $318.5M $321.1M -$2.7M CYPH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TTRX REV CYPH REV TTRX GROSS % CYPH GROSS % TTRX FCF CYPH FCF
FY 2025 $16.4M $115.0M — — -$2.6M -$43.9M
FY 2024 $5.0M $196.2M — — -$1.4M -$60.3M
FY 2023 — $243.7M — — — -$43.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TTRX // BETA —
CYPH // BETA —